Sagimet Biosciences Inc.
SGMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $141,078 | $98,615 | $353,676 | $353,676 |
| - Cash | $75,840 | $75,139 | $158 | $56,731 |
| + Debt | $78 | $65 | $211 | $348 |
| Enterprise Value | $65,316 | $23,541 | $353,729 | $297,293 |
| Revenue | $0 | $2,000 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $2,000 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$45,567 | -$30,740 | -$31,055 | -$23,719 |
| % Margin | – | -1,537% | – | – |
| Net Income | -$45,567 | -$27,876 | -$30,499 | -$24,442 |
| % Margin | – | -1,393.8% | – | – |
| EPS Diluted | -1.45 | -1.53 | -1.38 | -1.1 |
| % Growth | 5.2% | -10.9% | -25.5% | – |
| Operating Cash Flow | -$42,435 | -$23,766 | -$24,490 | -$21,710 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$42,435 | -$23,766 | -$24,490 | -$21,710 |